1876FL |
Drug Screen - Expanded, Fluid |
1876U |
Drug Screen - Expanded, Urine |
4282SP |
Synthetic Cannabinoids (Qualitative), Serum/Plasma |
4283U |
Synthetic Cannabinoid Metabolites-Expanded (Qualitative), Urine |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8031U |
Child Drug Exposure Screen, Urine |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8052U |
Postmortem, Expanded, Urine (Forensic) |
8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
8062U |
Postmortem, Expanded w/o Alcohol, Urine (Forensic) |
8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |